Cargando…

Substance P and its tachykinin NK1 receptor: a novel neuroprotective target for Parkinson's disease

Detalles Bibliográficos
Autores principales:	Thornton, Emma, Vink, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625501/ https://www.ncbi.nlm.nih.gov/pubmed/26604896 http://dx.doi.org/10.4103/1673-5374.165505

Ejemplares similares

Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease
por: Thornton, Emma, et al.
Publicado: (2012)

Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK(1) receptors
por: Palma, C, et al.
Publicado: (1999)

Targeting tachykinin receptors in neuroblastoma
por: Henssen, Anton G., et al.
Publicado: (2016)

Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation
por: Jones, Sarah, et al.
Publicado: (2008)

Ovarian steroids regulate tachykinin and tachykinin receptor gene expression in the mouse uterus
por: Pinto, Francisco M, et al.
Publicado: (2009)

Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi(8),Met(O(2))(11)]-Substance P
por: Suthiram, Janine, et al.
Publicado: (2023)

Role of the tachykinin NK(1 )receptor in a murine model of cigarette smoke-induced pulmonary inflammation
por: De Swert, Katelijne O, et al.
Publicado: (2009)

Anti-tumour activity of tachykinin NK(1)receptor antagonists on human glioma U373 MG xenograft
por: Palma, C, et al.
Publicado: (2000)

The Role of Substance P in Secondary Pathophysiology after Traumatic Brain Injury
por: Vink, Robert, et al.
Publicado: (2017)

Marked Effects of Tachykinin in Myositis Both in the Experimental Side and Contralaterally: Studies on NK-1 Receptor Expressions in an Animal Model
por: Song, Yafeng, et al.
Publicado: (2013)

The Wnt/β-catenin signaling: a multifunctional target for neuroprotective and regenerative strategies in Parkinson’s disease
por: Serafino, Annalucia, et al.
Publicado: (2022)

NK1 Receptor Blockade Is Ineffective in Improving Outcome following a Balloon Compression Model of Spinal Cord Injury
por: Leonard, Anna Victoria, et al.
Publicado: (2014)

Kinin Receptor Antagonists as Potential Neuroprotective Agents in Central Nervous System Injury
por: Thornton, Emma, et al.
Publicado: (2010)

Tachykinin receptors antagonism for asthma: a systematic review
por: Ramalho, Renata, et al.
Publicado: (2011)

Three tachykinins in mammalian brain
por: Harmar, Anthony J.
Publicado: (1984)

Pretreatment of caffeine leads to partial neuroprotection in MPTP model of Parkinson's disease
por: Bagga, Puneet, et al.
Publicado: (2016)

Why and how does light therapy offer neuroprotection in Parkinson's disease?
por: Mitrofanis, John
Publicado: (2017)

Bacterial melanin in rat models of Parkinson's disease: a potential neuroprotective strategy
por: Petrosyan, Tigran
Publicado: (2015)

Restoration of GABA(B) receptor expression in cerebral ischemia: a promising novel neuroprotective strategy
por: Bhat, Musadiq A., et al.
Publicado: (2023)

Evaluating rehabilitation interventions in Parkinson's disease with functional MRI: a promising neuroprotective strategy
por: Mallio, Carlo Augusto, et al.
Publicado: (2015)

Assessment of Tachykinin Receptor 3′ Gene Polymorphism rs3733631 in Rosacea
por: Karpouzis, Anthony, et al.
Publicado: (2015)

Hemokinin-1 induces transcriptomic alterations in pain-related signaling processes in rat primary sensory neurons independent of NK1 tachykinin receptor activation
por: Takács-Lovász, Krisztina, et al.
Publicado: (2023)

Sigma-1 receptor: a potential new target for Parkinson's disease?
por: Francardo, Veronica
Publicado: (2014)

The inositol metabolism pathway as a target for neuroprotective strategies
por: Nystuen, Arne M., et al.
Publicado: (2015)

Estrogen/Huntingtin: a novel pathway involved in neuroprotection
por: Nuzzo, Maria Teresa, et al.
Publicado: (2016)

Autocrine regulation of human sperm motility by tachykinins
por: Pinto, Francisco M, et al.
Publicado: (2010)

Neurogenic tachykinin mechanisms in experimental nephritis of rats
por: Rodionova, Kristina, et al.
Publicado: (2020)

Tachykinins and Kisspeptins in the Regulation of Human Male Fertility
por: Blasco, Víctor, et al.
Publicado: (2019)

Excitotoxicity-induced endocytosis as a potential target for stroke neuroprotection
por: Díaz-Guerra, Margarita
Publicado: (2020)

Tachykinin receptor 3 in the lateral habenula alleviates pain and anxiety comorbidity in mice
por: Zhang, Wen-Wen, et al.
Publicado: (2023)

Interleukin 4-induced neuroprotection and regulation of microglia activation as a therapeutic approach in the MPTP model of Parkinson's disease
por: Spittau, Björn
Publicado: (2017)

Fractalkine: multiple strategies to counteract glutamate receptors activation leading to neuroprotection
por: Lauro, Clotilde
Publicado: (2015)

Sigma-1 receptor and neuroprotection: current outlook and potential therapeutic effects
por: Li Volti, Giovanni, et al.
Publicado: (2016)

Reducing intrathecal pressure after traumatic spinal cord injury: a potential clinical target to promote tissue survival
por: Leonard, Anna V, et al.
Publicado: (2015)

Tachykinins modulate nociceptive responsiveness and sensitization: In vivo electrical characterization of primary sensory neurons in tachykinin knockout (Tac1 KO) mice
por: Gutierrez, Silvia, et al.
Publicado: (2019)

Molecular mechanisms of NMDA receptor-mediated excitotoxicity: implications for neuroprotective therapeutics for stroke
por: Li, Victor, et al.
Publicado: (2016)

Tachykinins Stimulate a Subset of Mouse Taste Cells
por: Grant, Jeff
Publicado: (2012)

Tachykinins: Neuropeptides That Are Ancient, Diverse, Widespread and Functionally Pleiotropic
por: Nässel, Dick R., et al.
Publicado: (2019)

Involvement of Substance P (SP) and Its Related NK1 Receptor in Primary Sjögren’s Syndrome (pSS) Pathogenesis
por: Rosso, Pamela, et al.
Publicado: (2023)

The innate immune system in Parkinson's disease: a novel target promoting endogenous neuroregeneration
por: Schlachetzki, Johannes CM, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jnh38orc86ta6md21pft01e3cn